WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product - BPAR-treatedBPAR CMAP, Biopsy Proven Acute Rejection (BPAR) is confirmed by Biopsy, Pathologist is located in Laboratory, Banff grade is staged as IB, defined time points including 6 months, Study treatments include Belatacept, Banff grade accounts for Mesangial matrix increase, Laboratory can be Central, Biopsy Proven Acute Rejection (BPAR) is assessed by Pathologist, Biopsy Proven Acute Rejection (BPAR) includes Treated BPAR episode, Banff grade accounts for Intimal arteritis, Banff grade is staged as IIB, Study treatments include Zortress, Study treatments are given in Dosages, Banff grade is staged as IIA, Treated BPAR episode is assessed in Laboratory, Biopsy Proven Acute Rejection (BPAR) is assessed in Laboratory, defined time points including 24 months, Banff grade accounts for Vascular fibrous intimal thickening, Study treatments include Astagraf XL, Anti-rejection therapy includes Study treatments